Document is current

Article History

Received: 20 December 2024

Accepted: 25 December 2024

First Online: 7 February 2025

Declarations

:

: CS reports Advisory Board from IDRX and NewBay; Advisory Board—Speaker—Grant from Deciphera and Blueprint and Speaker from Pharmamar and Roche.MA reports Speaker—Grant from Lilly, Astrazeneca and Roche and Grant from Takeda.NH Advisory Board—Speaker—Grant—Other from PharmaMar and Deciphera; Speaker from Asofarma and Other from Immunome, INBRX, COGENT, LIXTE, Synox, Abbisko, Lilly, Boehringer and Cebiotex.MASG reports Advisory Board—Speaker—Grant fromRoche Farma; Speaker—Grant from Pzifer; Grant from Astra Zeneca and PharmaMar and Speaker from Deciphera.JMT reports Advisory Board—Other from Pharmamar, GSK and Boehringer; Advisory Board—Speaker from Eisai and Deciphera; Speaker from Roche and Merck and Other from MSD.JMG, RSM, APR, AMD and ICG have nothing to disclose.

: The current study has been performed inaccordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

: For this type of study, no informed consent is required.